On Tuesday, April 13, HB 3000 was introduced to the Oregon legislature with several amendments, causing uproar in the cannabis industries, both hemp and marijuana.
The rise of Delta 8 sales (an artificially derived, intoxicating derivative of hemp extracts) sold in the open market, has caused several states to draft reasonable regulations to ensure safe consumer cannabis products.
Currently, the loopholes in regulation and lack of enforcement have allowed for wide distribution of the federally scheduled drug, with no oversight for processing efficacy, label requirements such as warnings and allowing for sales to minors.
HB 3000 proposes to regulate D8 into the OLCC market. The bill includes many other details that extends beyond D8, including regulating all hemp products into the OLCC market by 2023.
The bill still needs to pass, and public comment is encouraged as the HB 3000 moves through the legislature. The OLCC and OHA will be establishing workgroups to continue refining the regulations.
Here are key takeaways:
- OLCC to regulate cannabinoids, defined as “artificially derived and intoxicating.”
- Tetrahydrocannabinols higher than .3% Total THC
- Delta 9
- Delta 8
- Hemp derived products sold into the dispensary markets will have a THC maximum.
- By 2023, Hemp Processors and Manufacturers would be regulated by the OLCC Market.
For more information: Kelly.firstname.lastname@example.org